PHASE GENOMICS INC

Phase Genomics Inc. specializes in advanced genomic sequencing and bioinformatic analysis, leveraging proprietary proximity ligation and Hi-C technologies to enable high-quality draft genome assemblies from complex biological samples. Their core capabilities include long- and short-read DNA and RNA sequencing, library preparation for metagenomic and metagenome-assembled genomes, and end-to-end bioinformatic workflow execution using their Proxi-Meta platform. The company excels in extracting structural and spatial genomic insights from challenging samples such as fecal microbiomes, delivering solutions that bridge experimental biology with computational genomics. Their technical differentiators lie in their ability to resolve complex microbial communities and eukaryotic genomes without traditional culturing, offering unparalleled resolution in metagenomic context and chromatin architecture analysis. Phase Genomics has delivered genomic services primarily for the U.S. Department of Agriculture, supporting agricultural and animal health research through fecal sample sequencing and microbial community characterization. They have also supported the Department of Commerce with high-accuracy genome assembly projects, indicating a focus on foundational biological research that informs environmental, agricultural, and biotechnological applications. Their agency relationships reflect a pattern of collaboration with science-driven departments seeking advanced genomic tools for non-human biological systems. The contractor operates primarily under NAICS codes 541380 (Testing Laboratories and Services), 541690 (Other Scientific and Technical Consulting Services), and 621511 (Medical Laboratories), positioning them at the intersection of applied genomics, bioinformatics consulting, and specialized laboratory services. Their vertical specialization is in microbiome and livestock genomics, serving research communities focused on animal health, soil ecology, and food system sustainability. Phase Genomics Inc. is a small business headquartered in Seattle, Washington, with no federal certifications on record. Their geographic presence is concentrated in the Pacific Northwest, but their technical services support nationwide federal research initiatives. The company’s market positioning is as a niche provider of cutting-edge genomic analysis platforms for government-funded life sciences research.